Currently white blood cells have been used in the somatic cell gene therapy treatment for patients with ADA-SCID,but their short lifespan is prohibitive in the treatment plan.What other type of cell could be used,and is being tested,with better results?
A) Bone marrow stem cells
B) Red blood cells
C) Epithelial cells
D) T lymphocytes
E) B lymphocytes

Question

Quizplus · Accepted Answer

Bone marrow stem cells have the ability to differentiate and produce all types of blood cells, including immune cells. They have a longer lifespan than white blood cells and can continuously produce new immune cells, making them a better alternative for long-term gene therapy treatment. Studies have shown promising results in the use of bone marrow stem cells in gene therapy for ADA-SCID.

Currently White Blood Cells Have Been Used in the Somatic